Correlation of molecular biomarker concentrations between synovial fluid and saliva of the patients with temporomandibular disorders

Yaman, Deniz; Alpaslan, Cansu; Akca, Gülçin; Avcı, Emre

doi:10.1007/s00784-020-03310-8

Cited by 9 publications

(1 citation statement)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It is observed that peripheral tissue injury or nerve dysfunction can alter the status of neuropeptides and neurotransmitters that often lead to prolonged sensitization of peripheral pathways. 27 Additionally, role of these molecular neurotransmitter and peptides have been determined in mechanism of central sensitization which means amplification of pain by abnormally amplifying ascending peripheral input or dysregulation of inhibitory modulatory system. 28 Based on the involvement of these cytokines and neuronal molecules in painful TMD, we have categorized the molecular biomarkers as inflammatory cytokines including proteinases, neurotransmitters, neuropeptides, and growth factors.…”

Section: Role Of Molecular Biomarkers In Tmd Painmentioning

confidence: 99%

A comprehensive review on biomarkers associated with painful temporomandibular disorders

Shrivastava

Battaglino

2021

Int J Oral Sci

View full text Add to dashboard Cite

Pain of the orofacial region is the primary complaint for which patients seek treatment. Of all the orofacial pain conditions, one condition that possess a significant global health problem is temporomandibular disorder (TMD). Patients with TMD typically frequently complaints of pain as a symptom. TMD can occur due to complex interplay between peripheral and central sensitization, endogenous modulatory pathways, and cortical processing. For diagnosis of TMD pain a descriptive history, clinical assessment, and imaging is needed. However, due to the complex nature of pain an additional step is needed to render a definitive TMD diagnosis. In this review we explicate the role of different biomarkers involved in painful TMD. In painful TMD conditions, the role of biomarkers is still elusive. We believe that the identification of biomarkers associated with painful TMD may stimulate researchers and clinician to understand the mechanism underlying the pathogenesis of TMD and help them in developing newer methods for the diagnosis and management of TMD. Therefore, to understand the potential relationship of biomarkers, and painful TMD we categorize the biomarkers as molecular biomarkers, neuroimaging biomarkers and sensory biomarkers. In addition, we will briefly discuss pain genetics and the role of potential microRNA (miRNA) involved in TMD pain.

show abstract

Section: Role Of Molecular Biomarkers In Tmd Painmentioning

confidence: 99%